KOR ENG CHN
SCIENCE
Core Technology FECS TED Papers and Patents
OUTLINE

S.Biomedics owns two platform technologies with excellent technical power and expandability. We are currently developing cell therapy products that overcome the limitations of existing cell therapy products by using the two source technologies. We endeavor to enhance the technology and company value by expanding the therapy product area for various indications.

Pipeline
Overview

We use 2 core platform technologies to expand to 8 R&D pipelines.

image image image image image image image image image image